Skip to main content
The Statesman Examiner
Place a Classified Ad
Classified Display Ads
Professional Services Directory
View Full List
Standard & Poors 500
New York Composite
Loncar Cancer Immunotherapy ETF
Streaming Delayed Price
Updated: 2:19 PM EST, Jan 21, 2022
Add to My Watchlist
All news about Loncar Cancer Immunotherapy ETF
Legend Biotech Hits New 54-Week High
October 13, 2021
Biopharmaceutical company Legend BioTech (LEGN) hit a new 54-week high this Tuesday, up 103.4% this year. LEGN is a multinational biopharmaceutical company primarily engaged in the discovery and...
3 Promising Oncology Stocks To Consider Adding To Your Portfolio
June 14, 2021
With tech integration and DNA sequencing increasing the efficacy of potential cancer drugs in the pipeline, we believe biotech names AstraZeneca, Amgen and Incyte are worth adding to a portfolio.
Best Biotech Stocks & ETFs for mRNA, Gene Editing
April 29, 2021
2020 was the most challenging year in decades but it was great for scientific innovation, particularly in the biotech space.
As U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to Rally
December 03, 2020
Both stock index ETFs and biotech stocks and ETFs have been on a tear lately thanks to promising coronavirus vaccine developments from several major pharmaceutical companies. But this week, the U.K....
ETF Wrap: Size doesn’t matter
December 03, 2020
ETF Wrap is a briefing of what investors need to know about the exchange-traded fund sector, including exclusive commentary and interviews on the industry from MarketWatch
How Will Vaccine Arrivals Affect Biotech ETFs?
November 30, 2020
November has been a big month for stock and biotech ETFs, and with the Federal Aviation Administration announcing that it supported the “first mass air shipment” of coronavirus vaccines on Friday,...
Biotech ETFs Remain Hot As Investors Await Upcoming Vaccine
November 27, 2020
Healthcare stocks and ETFs are continuing to outperform as investors are optimistic about an upcoming vaccine for the coronavirus, which has been a blight on the globe since early this year. There has...
Biotech ETFs Poised for Gains after Moderna Vaccine News
November 16, 2020
Biotech ETFs are getting a boost along with stocks on Monday thanks to Moderna, which announced that its initial phase three trial data reveals a coronavirus vaccine that is over 94% effective. Shares...
Will Moderna Vaccine News Boost Biotech ETFs?
November 12, 2020
Monday saw stocks and index ETFs surge, after the announcement from Pfizer that the pharmaceutical giant had a vaccine candidate with an over 90% effectiveness in clinical trials. Now another biotech,...
ETF Wrap: the Groundhog Day of fiscal stimulus talks and the bet on volatility
October 22, 2020
ETF Wrap is a briefing of what investors need to know in the exchange-traded fund sector, including exclusive commentary and interviews on the industry from MarketWatch
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Terms and Conditions
Copyright © 2017 The Statesman Examiner | 220 South Main Street P.O. Box 271 | Colville, WA 99114 | (509) 684-4567
All property rights for the entire contents of this publication shall be the property of The Statesman Examiner.
No part hereof may be reproduced without prior written consent.
Request new password